This article is written for the industry, not for patients
Almost everything on Clinic Insider is written for the person considering a treatment. This small section is written for clinic owners and staff, and it is kept separate so that nobody mistakes one for the other. If you arrived here looking for guidance as a patient, the material you want is in checks before you agree.
The same editorial rule applies here as everywhere else on this site: we do not rank, rate or recommend businesses we have not assessed, and that includes agencies.
Marketing in aesthetics is a category with no barrier to entry, a great deal of specialist vocabulary, and buyers who are usually clinicians rather than marketers. That combination produces the same problem that patients face when choosing a practitioner: the person buying cannot easily evaluate what is being sold, so presentation substitutes for evidence.
What follows is a procurement method. It will not tell you who to hire, because we have not assessed any agency and would not pretend otherwise.
Start with the compliance question, because it is yours
This is the part most procurement conversations skip and it is the part with the largest downside.
Marketing produced for your clinic is your marketing. If it names a prescription only medicine, it engages the prohibition on advertising those medicines to the public. If it exaggerates results, presents atypical outcomes as typical, or uses before and after imagery that is not comparable, it engages the CAP Code. If an influencer posts about your clinic without disclosing the arrangement, that is your commercial arrangement.
The ASA rules against advertisers. Where a registered clinician is involved, their regulator's standards on promotion apply to them personally. An agency that produced the work will not be the party whose registration is at stake.
So the first question is not about growth. It is: who in your team knows the medicines advertising rules, and what happens if a campaign you produce results in an ASA ruling against us. An agency that has a clear answer, including named responsibility and an approval process, is describing an operation that has thought about this. One that treats it as a legal detail is transferring a risk to you without pricing it.
Who actually does the work
Ask who will be on the account, what proportion of their time you are buying, and what is subcontracted. Ask who wrote the case studies you were shown and whether that team still works there. Ask for the name of the person who will write the copy that goes out under your clinic's name, because in this sector copy is where compliance risk lives.
The pattern to watch for is a senior team in the pitch and a junior team on the account. It is not unique to this industry, and it is common in it.
What a clinic should insist on
- Written ownership of the domain, website, analytics, advertising accounts, content and patient data.
- A written data processing agreement wherever patient data is handled, given that it is special category data.
- Marketing consent for patient photography that is separate from consent to treatment.
- A named approval step before anything is published under the clinic's name.
- A notice period you could actually use, and a clear position on work in progress at termination.
Regulatory exposure for non compliant advertising sits with the advertiser, and with any registered clinician involved.
The contract, before the strategy
Read the commercial terms first. Minimum term, notice period, what happens to work in progress on termination, and whether fees are payable for a period after you leave.
Then ownership, which is where the real leverage sits. Establish in writing that your clinic owns the domain, the website, the analytics property, the advertising accounts, the customer data and the content. An agency holding your Google or Meta account in its own name creates a switching cost that has nothing to do with the quality of its work.
Then data protection. Patient data is special category data. Any arrangement in which an agency handles it needs a written processor agreement, and any use of patient photographs needs consent that specifically covers marketing use, which is a separate consent from treatment consent.
What is measured, and what is claimed
Leads are the number most commonly reported and the least informative. A lead volume figure tells you nothing about consultation attendance, conversion, treatment value, retention, or whether the enquiries were for the treatments you want to be doing.
Ask what will be measured end to end, who is responsible for the attribution model, and what happens if the numbers do not move. Ask specifically how organic and paid contributions are separated, because conflating them is the most common way growth is claimed rather than demonstrated.
Guaranteed rankings, guaranteed lead volumes, or a proprietary method that cannot be described. Nobody controls a search engine's ranking. A guarantee in that form is either meaningless or is achieved by buying traffic that would have arrived anyway.
References, and reading a published model
Ask for two references you can speak to directly, one current and one that has left. The second is more useful and is rarely offered.
Separately, it is worth reading how agencies in this category describe their own operating model in public, because a published model is a document you can test against the questions above. As one example of a UK agency that publishes its approach to clinic marketing in a form you can read and compare, Aesthetic Launch Lab sets out its positioning publicly. We reference it here as material to read, not as a recommendation: we have not assessed the agency, its work or its results, and this publication does not endorse businesses it has not assessed. Read it as one worked example alongside others and apply the same procurement questions to all of them.
Consider that the answer may not be an agency
For a single site clinic, the highest return work is often not marketing at all. It is the consultation process, the follow up, the aftercare, the complaints handling and the retention of existing patients. Those improve outcomes and revenue simultaneously, and they do not require anyone external.
An agency that raises this possibility during a pitch is worth more attention than one that does not, because it suggests they are able to describe the limits of what they sell.
One closing point, from the patient side
This publication spends most of its time telling patients to check registrations, ask who prescribes, and be suspicious of urgency and of results imagery. Clinics that market in the way we describe as a warning sign are generating short term enquiries and long term complaints.
The marketing that survives that scrutiny is the marketing that is accurate: named practitioners with checkable registrations, real prices, stated complication policies, standardised photography with intervals disclosed. That is a slower proposition to sell and a considerably more durable one, and any agency that cannot work within it is selling you a risk rather than a growth plan.